SCHEMBL31320165

SCHEMBL31320165

COC(=O)c1cc(C)nc(N2CCC(F)(F)CC2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 1/20 0.44
GBA1 P04062 1/20 0.42
PIK3CA P42336 1/20 0.42
PIK3CB P42338 1/20 0.42
KIF18A Q8NI77 4/20 0.40
KCNQ3 O43525 1/20 0.40
KCNQ2 O43526 1/20 0.40
CRBN Q96SW2 2/20 0.39
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 2/20 0.39
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
HPGD P15428 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
ROCK2 O75116 2/20 0.38
KDM5A P29375 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
WHR1 P49842 1/20 0.37
NAPEPLD Q6IQ20 1/20 0.37
LIMK1 P53667 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24213988 0.85 PTGER4 (0.55) PTGER4GBA1PIK3CAKIF18AKDM4E
SCHEMBL31320141 0.83 PTGER4 (0.46) PTGER4GBA1KIF18ANAPEPLDWNT1
SCHEMBL19367477 0.81 PIK3CA (0.60) PIK3CAPIK3CBALDH1A1KMT2AMEN1
SCHEMBL30615828 0.79 KIF18A (0.43) PTGER4GBA1KIF18ACRBNNAPEPLD
SCHEMBL475674 0.77 ALDH1A1 (0.43) KDM4EALDH1A1KMT2AMEN1L3MBTL1
SCHEMBL26646283 0.76 RBP4 (0.58) KIF18AKCNQ3KCNQ2KDM4EALDH1A1
SCHEMBL30600681 0.76 RBP4 (0.58) KIF18AKCNQ3KCNQ2KDM4EALDH1A1
SCHEMBL27457591 0.75 GBA1 (0.47) PTGER4GBA1KIF18AKDM4EALDH1A1
SCHEMBL19995500 0.75 PRKD1 (0.44) PIK3CAPIK3CBCRBNKDM4EALDH1A1
SCHEMBL31320279 0.74 KIF18A (0.45) KIF18AKCNQ3KCNQ2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250250264-A1 KIF18A INHIBITOR AND USE THEREOF Wuhan Humanwell Innovative Drug Research and Development Center Limited Company (CN) 2025-08-07 US disclosed
EP-4509505-A1 KIF18A INHIBITOR AND USE THEREOF Wuhan Humanwell Innovative Drug Research and Development Center Limited Company (CN) 2025-02-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250250264-A1 KIF18A INHIBITOR AND USE THEREOF KIF18A, KIF18B, KIF15 PTGER4 4639/4885GBA1 1587/4885PIK3CA 374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.